LabCritics
We cover the latest and the best in lab equipments, consumables and softwares, and also provides tra LabCritics is a part of Bioflukes
LabCritics is a weblog that is devoted to cover innovations in lab equipments, product performance reviews, practices and consumables that are pushing the advancement of discoveries in biological sciences.
13/05/2026
Human Longevity Inc introduces clinical grade whole genome sequencing for $599 .. once step closer to sub $100 genome..
Backed by an AI-driven insights platform..
MoleculeDAO announces $50K Award for Researchers in Asia for Drug Development | Email [email protected]
28/01/2017
Apply now!!
The Global BioAccelerator Initiative - RebelBio RebelBio is the Global BioAccelerator Initiative for Biotech & Synthetic Biology. We offer seed funding, lab space, key mentorship, & inspiring community.
Sub $100 Genome Sequencing
One Day Turnaround Times
Instrument Costs less than $1 million
Illumina Achieves Many First’s With the NovaSeq Sequencer Illumina, the leader in genome sequencing has announced its newest model of gene sequencer that costs under a million dollars, and is able to
01/11/2016
uBiome Pockets $22 Million to Dig Further in Your P**p
uBiome Pockets $22 Million to Dig Further in Your P**p uBiome has two new announcements today: the launch of its new SmartGut f***l microbiome test and a $22 million round of Series B funding aimed
01/10/2016
03/09/2016
One small step for genetic research, a huge step for space-exploration. - Oxford Nanopore Technologies
Nanopore Sequences Genes Very First Time in Space, Courtesy NASA Oxford Nanopore's MiniION sequencers have successfully sequenced genes in space for the very first time at NASA's International Space Station
28/07/2016
Implanting tumors in the same organ of origin in mice.
http://www.labcritics.com/xenopat-your-tumor-in-a-mouse-6610/
Xenopat: Your Tumor in a Mouse Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to
23/06/2016
Labcritics interview with Iproteos CEO Teresa Tarragó.
http://www.labcritics.com/teresa-tarrago-crowdfunding-is-a-funding-source-for-early-stage-biotechs-6595/
Teresa Tarragó: “Crowdfunding is a Funding Source for Early Stage Biotechs” Labcritics was at Iproteos' facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
Bangalore